Hepatocyte PPARα Is Essential for Triglyceride-Lowering Effect of Pemafibrate
International Journal of Molecular Sciences · 06.04.2026 · 27 (7) · 3308
DOI: 10.3390/ijms27073308 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.04.2026. Verfasst von Zhe Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Medical Research Promotion, Shinshu University Graduate School of Medicine, Matsumoto 390-8621, Japan. Hauptthemen laut MEDLINE: PPAR alpha, Hepatocytes, Benzoxazoles, Triglycerides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Shinshu Public Utility Foundation for Promotion of Medical Sciences, Japan Agency for Medical Research and Development (AMED), Program for Basic and Clinical Research on Hepatitis, Japan Agency for Medical Research and Development (AMED).
Abstract (Originalsprache)
We previously demonstrated that a clinically relevant dose of pemafibrate (PEM), a selective peroxisome proliferator-activated receptor α (PPARα) modulator (SPPARMα), reduces serum triglyceride (TG) levels in mice via hepatic PPARα activation. However, the specific contribution of hepatocyte PPARα remains unclear. To address this, male Ppara-floxed (Pparafl/fl) and hepatocyte-specific Ppara-disrupted (PparaΔHep) mice were fed a diet with or without a clinically relevant dose of PEM (0.00005%) for four weeks. In Pparafl/fl mice, PEM significantly reduced circulating TG and non-esterified fatty acid levels by enhancing hepatic fatty acid uptake and β-oxidation. In contrast, these effects were absent in PparaΔHep mice. Notably, PEM did not activate PPARα in extrahepatic tissues, including white/brown adipose tissue, kidney, and skeletal muscle in either genotype. These findings underscore the essential role of hepatocyte PPARα in mediating the pharmacological effects of PEM at clinically relevant doses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Global Medical Research Promotion, Shinshu University Graduate School of Medicine, Matsumoto 390-8621, Japan.
- Gastroenterology Department, University-Town Hospital of Chongqing Medical University, The Fourth Clinical College of Chongqing Medical University, Chongqing 401331, China.
- Department of Clinical Laboratory, The Second Hospital of Hebei Medical University, Shijiazhuang 050061, China.
- Postdoctoral Mobile Station of Clinical Medicine, Hebei Medical University, Shijiazhuang 050017, China.
- Department of Gastroenterology, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
- Institute for Biomedical Sciences, Shinshu University, Matsumoto 390-8621, Japan.
ORCID-Profile: Takero Nakajima, Takefumi Kimura, Naoki Tanaka
Förderung
- the Shinshu Public Utility Foundation for Promotion of Medical Sciences
- Japan Agency for Medical Research and Development (AMED), Program for Basic and Clinical Research on Hepatitis
- Japan Agency for Medical Research and Development (AMED)
- Shinshu Public Utility Foundation for Promotion of Medical Sciences
Zitieren
APA
Zhang, Z., Zhang, X., Qian, C., Diao, P., Nakajima, T., Kimura, T., Gonzalez, F. J., & Tanaka, N. (2026). Hepatocyte PPARα Is Essential for Triglyceride-Lowering Effect of Pemafibrate. International Journal of Molecular Sciences, 27(7), 3308. https://doi.org/10.3390/ijms27073308
Vancouver
Zhang Z, Zhang X, Qian C, Diao P, Nakajima T, Kimura T, et al. Hepatocyte PPARα Is Essential for Triglyceride-Lowering Effect of Pemafibrate. International Journal of Molecular Sciences. 2026;27(7):3308. doi:10.3390/ijms27073308
BibTeX
@article{Zhang2026,
author = {Zhang, Zhe and Zhang, Xuguang and Qian, Chufang and Diao, Pan and Nakajima, Takero and Kimura, Takefumi and Gonzalez, Frank J and Tanaka, Naoki},
title = {Hepatocyte PPARα Is Essential for Triglyceride-Lowering Effect of Pemafibrate},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {7},
pages = {3308},
doi = {10.3390/ijms27073308}
}
EUVIMED